MYH14 and cancer: In contrast to these anatomic measurements, studies that have evaluated myofilament protein content using biochemical approaches in both pre-clinical models (Acharyya et al., 2004) and patients (Eley et al., 2008) have suggested that atrophy in cancer is associated with a selective loss of the contractile protein myosin, with relative preservation of other contractile proteins.